Therapeutic Revolution In Dermatology
Links shared publicly online about this topic.
- 1,200total visits
Therapeutic Revolution In Dermatology
View full resource at medicalnewstoday.com
Tags: Dermatology
Most Recently Shared on May 1, 2010 at 2:06 pm By:
Therapeutic Revolution In Dermatology http://mnt.to/3C2R #dermatology
The Quiet Revolution of Mobile Health Applications : Skin & Allergy News
skinandallergynews.com — “Skin & Allergy News Digital Network is the online destination and multimedia properties of Skin & Allergy News, the independent news publication for the dermatology community. Our breaking news covers all areas of medical dermatology, dermatologic surgery, and aesthetic dermatology. We also provide the news by specialty interest: acne and rosacea, atopic dermatitis and eczema, cutaneous oncology, hair and nails, infectious diseases, pediatric dermatology, psoriasis and rheumatologic disorders, s” View full resource at skinandallergynews.com
Most Recently Shared on March 30, 2012 at 2:00 pm By:
Skin & Allergy News Health News
The Quiet Revolution of Mobile Health Applications http://t.co/rWYzmZbh
Particle, Pernix to develop new topical dermatology product | BioPortfolio.com
bioportfolio.com — “From BioPortfolio: Particle Sciences and Pernix Therapeutics have entered into an agreement to develop a new topical dermatology product for the pediatric market.” View full resource at bioportfolio.com
Most Recently Shared on March 22, 2012 at 12:32 pm By:
BioPF Dermatology Dermatology and Health News Feed
BioPortfolio News Particle Pernix to develop new topical dermatology product: Particle Science... http://t.co/As7HLdDv BioPortfolio News
Promising Therapeutic Target For Androgenetic Alopecia In Both Men And Women With Hair Loss And Thinning
medicalnewstoday.com — “Researchers from the Perelman School of Medicine at the University of Pennsylvania have identified an abnormal amount a protein called Prostaglandin D2 in the bald scalp of men with male pattern b” View full resource at medicalnewstoday.com
Most Recently Shared on March 22, 2012 at 9:05 am By:
MNT Dermatology News Dermatology and Health News
Promising Therapeutic Target For Androgenetic Alopecia In Both Men And Women With Hair Loss And Thinning http://t.co/YgiVfwIb #dermatology
Obagi® Medical Products Presents Study Results at American Academy of Dermatology - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: Obagi Medical Products, Inc. , a leader in topical aesthetic and therapeutic skin health systems, released the results of three new studies this weekend at the American Academy of Dermatology meeting in San Diego, CA.” View full resource at finance.yahoo.com
Most Recently Shared on March 20, 2012 at 4:38 pm By:
Obagi® Medical Products Presents Study Results at American Academy of Dermatology: Obagi Medical Products, Inc. ... http://t.co/zB1CPSzX
Obagi® Medical Products Presents Study Results at American Academy of Dermatology | BioPortfolio.com
bioportfolio.com — “From BioPortfolio: Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and therapeutic skin health systems, released the results of three new studies this we...” View full resource at bioportfolio.com
Most Recently Shared on March 20, 2012 at 1:48 pm By:
BioPF Dermatology Dermatology and Health News Feed
BioPortfolio News Obagi Medical Products Presents Study Results at American Academy of Dermat... http://t.co/9pvvSjQe BioPortfolio News
VBL Therapeutics Presents Positive Phase 2 Data for VB-201 in Psoriasis and Atherosclerosis at the Late-Breaking Abstract Session of the American Academy of Dermatology 70th Annual Meeting - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: VBL Therapeutics, a clinical stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that a Phase 2 sub-study of VB-201 in moderate to severe psoriasis patients with cardiovascular risk has successfully achieved its primary endpoint demonstrating a statistically significant reduction in vascular inflammation associated ...” View full resource at finance.yahoo.com
Most Recently Shared on March 17, 2012 at 1:37 am By:
VBL Therapeutics Presents Positive Phase 2 Data for VB-201 in Psoriasis and Atherosclerosis at the Late-Breaking... http://t.co/Znutigbd
VBL Therapeutics Presents Positive Phase 2 Data for VB-201 in Psoriasis and Atherosclerosis at the Late-Breaking Abstract Session of the American Academy of Dermatology 70th Annual Meeting | BioPortfolio.com
bioportfolio.com — “From BioPortfolio: VBL Therapeutics, a clinical stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today ann...” View full resource at bioportfolio.com
Most Recently Shared on March 16, 2012 at 11:10 pm By:
BioPF Dermatology Dermatology and Health News Feed
BioPortfolio News VBL Therapeutics Presents Positive Phase 2 Data for VB201 in Psoriasis and A... http://t.co/Xw0aLPnQ BioPortfolio News
New Therapeutic Target Against Leishmaniasis
medicalnewstoday.com — “Leishmaniasis is a serious parasitic disease with several forms, cutaneous mucocutaneous or visceral, respectively causing skin sores, ulceration and internal damage. The visceral form can be fata” View full resource at medicalnewstoday.com
Most Recently Shared on October 31, 2011 at 9:05 am By:
MNT Dermatology News Dermatology and Health News
New Therapeutic Target Against Leishmaniasis http://t.co/Qkd0Hk5T #dermatology
GEN | News Highlights:Dermira Raises $42M in Series A and Acquires Dermatology Therapeutics Firm Valocor
genengnews.com — “Newly formed Dermira will continue development of clinical-stage PDT for acne and preclinical topical acne and inflammatory skin disease candidates.” View full resource at genengnews.com
Most Recently Shared on October 21, 2011 at 11:43 am By:
Dermira raises $42M in series A, acquires dermatology therapeutics firm Valocor. http://t.co/E2xijIF8
Halozyme Announces Positive Results From Roche's Subcutaneous Herceptin Phase 3 Trial
medicalnewstoday.com — “Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug de” View full resource at medicalnewstoday.com
Most Recently Shared on October 19, 2011 at 9:06 am By:
Halozyme Announces Positive Results From Roche's Subcutaneous Herceptin Phase 3 Trial http://t.co/oYjmFNW4 #diabetes
MedWire News - Dermatology - Algorithm for psoriasis treatment in elderly
medwire-news.md — “MedWire News A new treatment algorithm, developed by the Medical Board of the National Psoriasis Foundation, outlines several therapeutic options for elderly patients with psoriasis. MedWire News” View full resource at medwire-news.md
Most Recently Shared on September 4, 2011 at 10:38 am By:
Algorithm for psoriasis treatment in elderly: A new treatment algorithm, developed by the Medical Board of the N... http://t.co/MsA58f4
It's All in the Translation : Internal Medicine News
internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre” View full resource at internalmedicinenews.com
Most Recently Shared on September 2, 2011 at 5:48 pm By:
Bob Finn - Medical News Net Health News
Translational medicine in rheumatology has led to ground-breaking drug discoveries and therapeutic advances. http://t.co/FplfNp3
Allergan to pay $275 million for skin care company | million, vicept, allergan - Business - The Orange County Register
ocregister.com — “Business: Allergan to pay $275 million for skin care company | million, vicept, allergan, company, therapeutics, development, skin, rosacea, dermatology, clinical” View full resource at ocregister.com
Most Recently Shared on July 20, 2011 at 7:22 pm By:
Shalona Anuj, PhD PhD, Doctor, Organic Advocate, and Skin and Beauty
Allergan to pay up to $275 million for skin care firm http://bit.ly/niT7LA
Allergan, Inc. to Acquire Privately Held Dermatologic Company, Vicept Therapeutics - Drugs.com MedNews
drugs.com — “- Vicept Therapeutics successfully completed a Phase II clinical development program of a novel topical cream for the treatment of the erythema of rosacea - Acq” View full resource at drugs.com
Most Recently Shared on July 19, 2011 at 3:14 pm By:
Drugs and Devices OW OW Health
Allergan, Inc. to Acquire Privately Held Dermatologic Company, Vicept Therapeutics: - Vicept Therapeutics ... http://bit.ly/o8ywOd #drug
Facials & Skin Care | Atlanta Duluth GA | Laser Lights Cosmetic Laser Center
atlaserlights.com — “Laser Lights Cosmetic Laser Center in Duluth, GA, north of Atlanta, also perform an array of medicated and therapeutic facials designed to custom treat skin conditions such as acne, rosacea, dry skin, wrinkles, and hyperpigmentation.” View full resource at atlaserlights.com
Most Recently Shared on July 18, 2011 at 5:35 pm By:
David M. Whiteman MD Physician, Doctor, Surgeon, and Plastic Surgeon
RT @AtLaserLights: We offer #facials in addition to our #LaserTreatments. See which one is right for you. http://tinyurl.com/3ktz6gd
Advertisement
